NCT07136324View on ClinicalTrials.gov

Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2028

Conditions
Pancreatic Cyst
Interventions
DEVICE

EUS-guided RFA treatment

A 19-gauge EUS-RFA catheter will be inserted into pancreatic lesions under EUS guidance. RFA energy is then applied in 2-10 cycles with each cycle lasting about 10-30 seconds and the power setting ranging from 10-30 Watts.

Trial Locations (1)

77054

Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT07136324 - Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry | Biotech Hunter | Biotech Hunter